drugset / Trial / NCT03129347

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

NCT03129347

Phase 1 Completed 14 enrolled National Institute on Drug Abuse (NIDA)
RandomizedCrossoverTriple-blindTreatment

Summary

This study will be to compare the pharmacokinetics of nalmefene administration intranasal with and without an absorption enhancer compared to an intramuscular injection.

Timeline

Start
2017-06-01
Primary completion
2017-06-09
Completion
2017-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalmefene Small molecule Intranasal